During the critical period of winter epidemic prevention and control, global vaccine research and development have also made significant progress. The successful approval of Pfizer's vaccine and then the vaccine rolling out across several countries has brought a new dawn to this year-long fight against the COVID-19 epidemic. However, in addition to the effectiveness of vaccines, large-scale vaccination also faces many challenges in production, transportation, storage and vaccination. At the same time, Pfizer's vaccine -70 ℃ strict transportation and storage conditions creates a higher demand for the safety and efficiency of cold chain logistics.
Due to the surge in demand, all states, cities and hospitals in the United States are scrambling to purchase vaccine cold chain equipment to cope with the need for large quantities of vaccine transportation and storage. Just last Friday, nearly one hundred Haier Biomedical Intelligent Control Cold Chain Transport Coolers were successfully sent to the United States to help with local anti-epidemic work.
In this tense situation, since the order was confirmed, the Haier Biomedical team worked together to implement the “Rendanheyi” spirit, timely adjusted countermeasures, connected all production links, and strictly controlled quality while improving efficiency. It took only four days to complete all the work from order confirmation to loading and shipping. Finally the products were approved and shipped to the United States by airfreight.